Mantle-Cell Lymphoma (Multiple Lymphomatous Polyposis) of the Entire GI Tract

Spyridon Michopoulos; Kalliopi Petraki; Charis Matsouka; Efstathios Kastritis; Heleni Chrysanthopoulou; Meletios A Dimopoulos

doi:10.1200/jco.2007.14.9856

Related publications

Article2023

Treatment approaches for patients with TP53-mutated mantle cell lymphoma

Thomas E. Lew, Adrian Minson, Michael Dickinson, Sasanka M. Handunnetti, Piers Blombery, Amit Khot, Mary Ann Anderson, David Ritchie, Constantine S. Tam, John F. Seymour

Article2024

Anlotinib Inhibiting Mantle Cell Lymphoma Proliferation and Inducing Apoptosis through PI3K/AKT/mTOR Pathway

Jiaping Wang, Zhijuan Xu, Yanli Lai, Yanli Zhang, Ping Zhang, Qitian Mu, Shujun Yang, Lixia Sheng, Guifang Ouyang

Current Molecular Medicine

Article2021

T-Cell Replete Allogeneic Stem Cell Transplant Is an Effective Treatment Option for Patients with TP53 mutated Mantle Cell Lymphoma

Edward R. Scheffer Cliff, Thomas E. Lew, Piers Blombery, Michael Dickinson, Constantine S. Tam, John F. Seymour, Ashish Bajel, David Ritchie, Amit Khot

Letter2021

T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease

Thomas E. Lew, Edward R. Scheffer Cliff, Michael Dickinson, Constantine S. Tam, John F. Seymour, Piers Blombery, Ashish Bajel, David Ritchie, Amit Khot

Article2023

Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma

Núria Profitós-Pelejà, Marcelo Lima Ribeiro, J. Parra, Miranda Fernández-Serrano, Pau Marin-Escudero, Adar Makovski-Silverstein, Stephen C. Cosenza, Manel Esteller, Gaël Roué